Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypochlorous Acid via Ultrasonic Atomization for Blepharitis
NCT05608980Unknown
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, open-label trial of hypochlorous acid in blepharitis (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoints: Ocular Surface Disease Index at 2 weeks, Meibum quality score at 2 weeks and 2 more. Status: unknown.
02
Drugs
hypochlorous acid
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT05608980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05608980.